Evidence map›Paper›PMID 26380175›Full record

ReviewTranslational lung cancer research2015

Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions.

Graham W Warren, Kenneth D Ward

Open access · greenAbstract readReview
In one paragraph

Review in Translational lung cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Smoking Cessation in Cancer Survivors.Korean journal of family medicine · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
  10. Article
  11. Article
  12. Considering Systemic Barriers to Treating Tobacco Use in Clinical Settings in the United States.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Review
  13. Article
  14. Article
  15. Tobacco smoking after diagnosis of cancer: clinical aspects.Translational lung cancer research · 2019
    Review
  16. Review
  17. Article
  18. Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2018
    Review
  19. Review
  20. Treating Nicotine Dependence and Preventing Smoking Relapse in Cancer Patients.Expert review of quality of life in cancer care · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Graham W Warren1 Department of Cell and Molecular Pharmacology and Experimental Therapeutics and Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA ; 2 Division of Social and Behavioral Sciences, School of Public Health, University of Memphis, Memphis, TN, USA.
Kenneth D Ward1 Department of Cell and Molecular Pharmacology and Experimental Therapeutics and Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA ; 2 Division of Social and Behavioral Sciences, School of Public Health, University of Memphis, Memphis, TN, USA.
MUSC Hollings Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tobacco use is the largest risk factor for lung cancer and many lung cancer patients still smoke at the time of diagnosis. Although clinical practice guidelines recommend that all patients receive evidence-based tobacco treatment, implementation of these services in oncology practices is inconsistent and inadequate. Multidisciplinary lung cancer treatment programs offer an ideal environment to optimally deliver effective smoking cessation services. This article reviews best practice recommendations and current status of tobacco treatment for oncology patients, and provides recommendations to optimize delivery of tobacco treatment in multidisciplinary practice.

Indexed as

Lung cancermultidisciplinary treatmentsmoking cessationtobacco

Identifiers

PMID26380175
PMCPMC4549462
OpenAlexW2173112342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.